Opinion: What a recent op-ed got wrong about our Covid study
“The appropriate counter to Covid revisionism is careful, rigorous, and honest assessment of the U.S. response.”
Recent health headlines from STAT News.

Manage alerts for this article Email this article Share this article Highlights UCSD researchers have spent years building trust in communities of unhoused people who use drugs in San Diego and across the border in…

“The appropriate counter to Covid revisionism is careful, rigorous, and honest assessment of the U.S. response.”

“Too often, regulatory tools authorized to speed patient access to breakthrough treatments are being used in ways that…

“The ADA is no longer what we’d call a profile in courage,” write Adam Marcus and Ivan Oransky of Retraction Watch.

Is the FDA taking inconsistent approaches to Duchenne drugs? And how will a new batch of drug executives shake up…

In win for RFK Jr., Senate committee sends nominations of Erica Schwartz for CDC director and Sean Kaufman for ASPR to…

Federal judge denied 26 states’ request to postpone the implementation of Medicaid work requirements announced in June.

You can reach Theresa on Signal at theresagaff.97.Helen BranswellHelen Branswell covers issues broadly related to…

Studies tied to Red Bull helped block warning labels about drinking alcohol along with energy drinks. Independent…

You can reach Theresa on Signal at theresagaff.97. Might I suggest you order yourself a delicious sandwich for lunch…

At a highly anticipated Senate hearing, Anthony Fauci evoked his Fifth Amendment right to refuse to answer questions…

An open letter to the board of the American Diabetes Association said the board had badly mishandled an incident at…

You can reach Jonathan on Signal at jwosen.27. For nearly half a century, the federal government encouraged…

Plus: Democrats take on Trump over IVF, and Trump's White House releases a new science funding blueprint.

New GSK CEO Luke Miels outlined his strategy to help the company navigate a patent cliff and get on a path toward…

In this edition of STAT Health Tech: A chat with Whoop's new chief medical officer, an update on CMS health tech…

The FDA said a Capricor stem cell treatment for Duchenne muscular dystrophy did not meet a Phase 3 trial's objectives…

The Centers for Medicaid and Medicare Services marked one year of its Health Tech Ecosystem initiative, unveiling…

The article reflects on the shift in perspective at the 2026 Alzheimer’s Association International Conference, noting…

Biotech companies are racing to cure alpha-1 antitrypsin deficiency, AATD, fueling patent disputes, startup…

The world risks a resurgence of the HIV epidemic after international financing to combat the disease suffered a…

Confidential tips can be sent on Signal at JasonMast.77. RA Capital and a fleet of other investors are putting $175…

Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating…

Ahead of a hearing, the FDA raised questions about the benefits of a Duchenne treatment from Capricor Therapeutics,…

An FDA advisory panel serves some peptide wins, a measles record, and more health news from Morning Rounds

Argenx plans to buy Forte Biosciences for $2.2 billion, expanding its pipeline of drugs that could treat multiple…

From new hires to departures, promotions, and hires, here are the latest comings and goings in the pharma industry.

Centers for Disease Control and Prevention logged 2,318 cases of measles as of Thursday, according to an agency update…

Robert F. Kennedy Jr. has lauded peptides and said he takes them himself.

“Consumers should not be faced with a trade-off between nutrition and food safety,” writes Susan Mayne, former…

The national security framing of the discussion around pharmaceutical supply chain vulnerabilities is a distraction,…

A federal loan program made it possible for Gauri Gurumurthy to pursue medicine. Now that program is changing.

Unexpected alliances among Republicans and Democrats were on display over a bill meant to rein in ultra-processed foods.

The Trump administration released its blueprint for U.S. science, calling for shifting hundreds of billions of…

Her interests include ultra-processed foods; smoke-free tobacco; and wellness trends like perimenopause products and…

Congress is scrambling to advance a slew of health care bills before an August recess. Price transparency and prior…

The Trump administration said it was deferring more than $1 billion in Medicaid payments to Minnesota and California…

Sonothera is developing a new way to deliver genes into cells that, if borne out, could have a big impact on muscular…

He previously served as senior adviser for children, youth, and families at the Substance Abuse and Mental Health…

MDCalc is launching a quality-rating system for the more than 800 clinical calculators used to assess disease risk,…

Advocates worry that excluding trans youth in some way from LGBTQ+ counseling services provided through the 988 crisis…

The government of Uganda has gone quiet on an outbreak of the deadly Marburg virus that it reported late last month,…

Sean Kaufman, Trump's pick for a key pandemic preparedness role, has questioned vaccines and criticized the CDC.

FDA's new CBER chief promises normalcy, an weight loss drug without GLP-1s, and more biotech news from The Readout

The Ebola outbreak in eastern Congo “continues to outpace the response efforts,” the WHO’s emergencies chief said on…

OpinionFirst Opinion It looks like your doctor and talks like your doctor. But it’s not your doctor Deepfakes raise a…

America's hidden alcohol epidemic — the toll, emerging risks, shifting usage, and economic stakes — broken down in 10…

The results of a recent AI competition show that better data trumps bigger models when it comes to predicting…

They also reviewed scientific literature, addiction treatment protocols, laws, public health guidance, and lobbying…

A group of AIDS activists obtained an R&D pact at the heart of a settlement between the U.S. government and Gilead…
WeSearch's declared handling of STAT News's content. Indexing, snippets, summaries, retrieval and training are separate questions — see the rights registry or read this source's machine-readable record.